Transforming the understanding of brain immunity

G Castellani, T Croese, JM Peralta Ramos, M Schwartz - Science, 2023 - science.org
Contemporary studies have completely changed the view of brain immunity from envisioning
the brain as isolated and inaccessible to peripheral immune cells to an organ in close …

Brain regulatory T cells

A Liston, E Pasciuto, DC Fitzgerald… - Nature Reviews …, 2024 - nature.com
The brain, long thought to be isolated from the peripheral immune system, is increasingly
recognized to be integrated into a systemic immunological network. These conduits of …

Identification of senescent, TREM2-expressing microglia in aging and Alzheimer's disease model mouse brain

N Rachmian, S Medina, U Cherqui, H Akiva… - Nature …, 2024 - nature.com
Alzheimer's disease (AD) and dementia in general are age-related diseases with multiple
contributing factors, including brain inflammation. Microglia, and specifically those …

Blood and CSF chemokines in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis

F Zhou, Y Sun, X ** all options open
R Arfaei, N Mikaeili, F Daj, A Boroumand… - International …, 2024 - Elsevier
Abstract Alzheimer's disease (AD), as a neurodegenerative disorder, distresses the elderly
in large numbers and is characterized by β-amyloid (Aβ) accumulation, elevated tau protein …

PD-L1/PD-1 pathway: a potential neuroimmune target for pain relief

D Deng, T Zhang, L Ma, W Zhao, S Huang, K Wang… - Cell & Bioscience, 2024 - Springer
Pain is a common symptom of many diseases with a high incidence rate. Clinically, drug
treatment, as the main method to relieve pain at present, is often accompanied by different …

The synergistic potential of combining PD-1/PD-L1 immune checkpoint inhibitors with NOD2 agonists in Alzheimer's disease treatment

M Ghareghani, S Rivest - International Journal of Molecular Sciences, 2023 - mdpi.com
Our research over the past decade has compellingly demonstrated the potential of
Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) receptor agonists …